Exact Mass: 732.1690272

Exact Mass Matches: 732.1690272

Found 33 metabolites which its exact mass value is equals to given mass value 732.1690272, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Oolongtheanin

5,7-Dihydroxy-2-[6,9,10-trihydroxy-5-oxo-3-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(8),3,9,11-tetraen-12-yl]-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid

C36H28O17 (732.1326)

Oolongtheanin is found in tea. Oolongtheanin is isolated from Camellia sinensis var. viridis (oolong tea). Isolated from Camellia sinensis variety viridis (oolong tea). Oolongtheanin is found in tea.

Methyl lithospermate B

C37H32O16 (732.169)

1,6-bis(1-hydroxy-4-oxo-2,5-cyclohexadiene-1-acetyl)-2-benzeneacetyl-3-(para-hydroxybenzeneacetyl)-beta-glucopyranoside|jacaglabroside D

C38H36O15 (732.2054)

1,6-bis(1-hydroxy-4-oxo-2,5-cyclohexadiene-1-acetyl)-2-(para-hydroxybenzeneacetyl)-3-benzeneacetyl-beta-glucopyranoside|jacaglabroside C

C38H36O15 (732.2054)

epigallocatechin-(4beta->6)-epigallocatechin-(4beta->S)benzylthioether

C37H32O14S (732.1513)

9-Methyl salvianolate B

(2R)-3-(3,4-dihydroxyphenyl)-2-[(2R,3R)-2-(3,4-dihydroxyphenyl)-4-[(E)-3-[(2R)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy-3-oxoprop-1-enyl]-7-hydroxy-2,3-dihydro-1-benzofuran-3-carbonyl]oxypropanoic acid

C37H32O16 (732.169)

9''-Methyl salvianolate B is a phenolic compound isolated from Radix Salvia miltiorrhizae[1]. 9''-Methyl salvianolate B is a phenolic compound isolated from Radix Salvia miltiorrhizae[1].

Oolongtheanin

5,7-dihydroxy-2-[6,9,10-trihydroxy-5-oxo-3-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)-7-oxatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,9,11-tetraen-12-yl]-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C36H28O17 (732.1326)

R788 (disodium hexahydrate)

C23H24FN6Na2O9P.6H2O (732.1756)

iralukast

C38H36F3NaO8S (732.1981)

Bis(2,5-diphenyloxazole-C2,N)(acetylacetonato)iridium(III)

C35H27IrN2O4 (732.16)

R788 disodium hexahydrate

C23H36FN6Na2O15P (732.1756)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

(2s,3as,6r,7as)-1-[(2r,3r)-2-{[(2r)-3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-n-(4-carbamimidamidobutyl)-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H45BrN6O9S (732.2152)

jacaglabroside c

C38H36O15 (732.2054)

(2r,3s,4s)-4-(benzylsulfanyl)-6-[(2r,3r,4s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C37H32O14S (732.1513)

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-4-{[2-(3-hydroxyphenyl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-4-{[2-(3-hydroxyphenyl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

C38H36O15 (732.2054)

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-4-{[2-(4-hydroxyphenyl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-4-{[2-(4-hydroxyphenyl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

C38H36O15 (732.2054)

(2r,3s,4s)-4-(benzylsulfanyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C37H32O14S (732.1513)

(3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-4-{[2-(3-hydroxyphenyl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl)methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

C38H36O15 (732.2054)

1-(2-{[3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl)-n-(4-carbamimidamidobutyl)-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H45BrN6O9S (732.2152)

4-(benzylsulfanyl)-6-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C37H32O14S (732.1513)

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-5-{[2-(4-hydroxyphenyl)acetyl]oxy}-4-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

[(2r,3r,4s,5r,6s)-3-hydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-5-{[2-(4-hydroxyphenyl)acetyl]oxy}-4-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate

C38H36O15 (732.2054)

(2r,3r,4s)-4-(benzylsulfanyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C37H32O14S (732.1513)

1-[(2r,3s)-2-{[3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-n-(4-carbamimidamidobutyl)-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H45BrN6O9S (732.2152)

(1r)-1-[(1r,2r,10r,11s,12s)-5-[(5s,6s)-5-[(1r)-1-(acetyloxy)ethyl]-1,6-dihydroxy-6-methyl-8,9,10-trioxo-5,7-dihydroanthracen-2-yl]-2,4,12-trihydroxy-12-methyl-9,14-dioxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-11-yl]ethyl acetate

(1r)-1-[(1r,2r,10r,11s,12s)-5-[(5s,6s)-5-[(1r)-1-(acetyloxy)ethyl]-1,6-dihydroxy-6-methyl-8,9,10-trioxo-5,7-dihydroanthracen-2-yl]-2,4,12-trihydroxy-12-methyl-9,14-dioxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-11-yl]ethyl acetate

C38H36O15 (732.2054)

4-(benzylsulfanyl)-8-[3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C37H32O14S (732.1513)